| DAA591 |
Cancer of esophagus |
Pathological |
oesophagus |
Human |
— |
SeriesMorbidity |
|
| DAA991 |
Decreased function of epithelial barriers |
Physiological |
lung, oral cavity, pharynx, oesophagus, stomach, intestine, epidermis |
Human |
— |
— |
|
| DAA829 |
Decrease in amplitude of peristaltic pressure wave in upper esophogeal sphincter |
Physiological |
oesophagus |
Human |
— |
— |
|
| DAA852 |
Deficiencies in generating secondary peristaltic contractions |
Physiological |
oropharynx, oesophagus |
Human |
— |
— |
|
| DAA850 |
Dysphagia incidence increases |
Physiological |
oropharynx, oesophagus |
Human |
— |
— |
|
| DAA853 |
Esophageal acid contact time increased |
Physiological |
oesophagus |
Human |
— |
— |
|
| DAA854 |
More severe manifestations of gastroesophageal reflux disease |
Pathological |
oesophagus, stomach |
Human |
— |
— |
|
| DAA857 |
Myenteric plexus neuron number decreases |
Physiological |
oesophagus, stomach, intestine |
Human |
— |
— |
|
| DAA851 |
Peristaltic amplitude is diminished |
Physiological |
oropharynx, oesophagus |
Human |
— |
— |
|